Ann Surg Oncol

1. MARTINEZ AE, Webber A, Davis L, Nigam A, et al
   Disparities in Surgical Care of Patients with Colorectal Cancer Liver Metastases.
   Ann Surg Oncol. 2026 Mar 14. doi: 10.1245/s10434-026-19483.
   

   >> Share

   
   
2. VALDES N, Diaz L, Torrico P, Crespo I, et al
   Targeted Preoperative Nutritional Support within an Enhanced Recovery After Surgery Program for Malnourished Colorectal Cancer Patients: Postoperative Outcomes Comparable to Well-Nourished Patients in a Prospective Single-Center Cohort.
   Ann Surg Oncol. 2026 Mar 13. doi: 10.1245/s10434-025-18778.
   

   >> Share

   
   

   
   BMC Cancer

3. HOU S, Wu X, Zhu H, Yao Y, et al
   The prognostic value of immunoscore in colorectal cancer liver metastases: a meta-analysis reveals the superiority of metastatic over primary tumor profiling.
   BMC Cancer. 2026 Mar 14. doi: 10.1186/s12885-026-15867.
   

   >> Share

   
   
4. SIEGEL R, Dittrich L, Plewe J, Denecke T, et al
   PROTECTOR / FIRE?10: study protocol for a prospective, randomized, open-label, multicenter phase III trial to investigate the efficacy of preoperative systemic therapy in advanced colon cancer.
   BMC Cancer. 2026 Mar 20. doi: 10.1186/s12885-026-15682.
   

   >> Share

   
   

   
   BMC Gastroenterol

5. LIANG J, Chen W, Yang J, Huang M, et al
   Laparoscopic-assisted vs open surgery for synchronous colorectal cancer: a retrospective cohort study of short-term and long-term outcomes.
   BMC Gastroenterol. 2026;26:176.
   

   >> Share

   
   
6. INOUE A, Nishizawa Y, Hashimoto M, Ozato Y, et al
   Clinicopathological characteristics and prognostic outcomes in consecutive Japanese patients with high microsatellite-instability colorectal cancer: real-world data from universal screening.
   BMC Gastroenterol. 2026 Mar 13. doi: 10.1186/s12876-026-04696.
   

   >> Share

   
   

   
   Br J Cancer

7. MARTIN S, Elomaa H, Vayrynen JP, Ahtiainen M, et al
   Tumour immune contexture and immune evasion in sporadic and Lynch syndrome-associated microsatellite unstable colorectal cancers.
   Br J Cancer. 2026;134:1019-1030.
   

   >> Share

   
   
8. HUANG Q, Zhao J, Zhang Y, Zhou Y, et al
   eIF3i facilitates NELFCD translation to promote metastasis via regulating EMT and invadopodia.
   Br J Cancer. 2026;134:996-1005.
   

   >> Share

   
   

   
   Br J Surg

9. IMAM I, Nilsson PJ, Khan T, Angenete E, et al
   Locoregional and systemic control after total neoadjuvant therapy with short-course radiotherapy for locally advanced rectal cancer: long-term outcomes from the LARCT-US study.
   Br J Surg. 2026;113:znag014.
   

   >> Share

   
   

   
   Cancer Res

10. ZHANG S, Zhou L, Hong B, van den Heuvel APJ, et al
    Editor's Note: Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.
    Cancer Res. 2026;86:1526.
    

    >> Share

    
    

    
    Clin Cancer Res

11. AHN DH, Barzi A, Ridinger M, Samuelsz E, et al
    Correction: Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study.
    Clin Cancer Res. 2026;32:1180.
    

    >> Share

    
    
12. HILLSON LVS, McMahon RK, Galbraith NJ, McCulloch AK, et al
    Differential Immunologic Effects of Short-Course and Long-Course Radiotherapy in Locally Advanced Rectal Cancer.
    Clin Cancer Res. 2026;32:1145-1156.
    

    >> Share

    
    

    
    Gastroenterology

13. NEGRI F, Valdivia PC, Nervi G
    Translating RNA blood-based test to clinical practice in early-onset colorectal cancer: promise and open questions.
    Gastroenterology. 2026 Mar 14:S0016-5085(26)00240.
    

    >> Share

    
    

    
    Gastrointest Endosc

14. ANDERSON JC, Hisey WM, Robinson CM, Limburg PJ, et al
    Anatomical location of colorectal neoplasia in patients with positive stool test (multitarget stool deoxyribonucleic acid or fecal immunochemical test) results: data from the New Hampshire Colonoscopy Registry.
    Gastrointest Endosc. 2026;103:762-770.
    

    >> Share

    
    
15. YAMAMURA T, Nakamura M, Hiramatsu M, Uchida G, et al
    Effectiveness of self-assembling peptide in reducing bleeding after colorectal endoscopic submucosal dissection.
    Gastrointest Endosc. 2026;103:747-759.
    

    >> Share

    
    
16. DE SIRE R, Spadaccini M, De Deo D, Massimi D, et al
    Underwater versus traction-assisted endoscopic submucosal dissection for colorectal lesions: a network meta-analysis of randomized controlled trials.
    Gastrointest Endosc. 2026;103:689-697.
    

    >> Share

    
    
17. PERRY NJ, Bhatte S, Triggs JR, Leung G, et al
    Extended surveillance after piecemeal endoscopic mucosal resection: a safe approach to initial surveillance in low-risk patients.
    Gastrointest Endosc. 2026;103:794-798.
    

    >> Share

    
    
18. SCALVINI D, Maimaris S, Cappellini A, Lusetti F, et al
    DIAGNOSTIC YIELD AND USEFULNESS OF TERMINAL ILEAL INTUBATION IN ASYMPTOMATIC PATIENTS UNDERGOING COLONOSCOPY FOR COLORECTAL CANCER SCREENING OR POST-POLYPECTOMY SURVEILLANCE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Gastrointest Endosc. 2026 Mar 13:S0016-5107(26)00201.
    

    >> Share

    
    
19. KOUNTOURAS J, Zavos C, Polyzos SA, Tzilves D, et al
    Endoscopist detection of Helicobacter pylori-related adenomas may be associated with an increased risk of neoplasia during follow-up colonoscopies, by initial combined conventional histology and immunohistochemical testing in colorectal cancer screeni
    Gastrointest Endosc. 2026;103:834-835.
    

    >> Share

    
    
20. YU Z, Bi X, Yang X
    Performance comparison of qualitative and quantitative fecal immunochemical tests in colorectal cancer screening: suggestions for improving the accuracy of test.
    Gastrointest Endosc. 2026;103:833-834.
    

    >> Share

    
    

    
    Gut

21. JANSSEN KP, Basic M, Bolsega S, Metwaly A, et al
    Extrinsic lipids are absorbed and accumulate in colorectal cancer.
    Gut. 2026 Mar 19:gutjnl-2025-336377. doi: 10.1136/gutjnl-2025-336377.
    

    >> Share

    
    

    
    Int J Cancer

22. ZIEGER V, Woehr E, Traichel J, Brummer T, et al
    Impact of non-genetic heterogeneity of BRAF-mutant colon cancer organoids on growth kinetics, drug sensitivity and Wnt dynamics.
    Int J Cancer. 2026 Mar 15. doi: 10.1002/ijc.70453.
    

    >> Share

    
    
23. LAVEN-LAW G, Jedi M, Cornthwaite KJ, Lowe MT, et al
    Effect of chemoradiation treatment on methylated BCAT1 and IKZF1 in rectal cancer.
    Int J Cancer. 2026;158:2658-2673.
    

    >> Share

    
    

    
    Int J Colorectal Dis

24. IMAIZUMI J, Shida D, Azuma Y, Ito G, et al
    Robotic en bloc resection for transverse colon cancer with a malignant colojejunal fistula: a case report.
    Int J Colorectal Dis. 2026;41:81.
    

    >> Share

    
    
25. YU Y, Bao W, Chen J, Li Y, et al
    SENP3 drives colorectal cancer progression by enhancing GDF15 expression.
    Int J Colorectal Dis. 2026;41:80.
    

    >> Share

    
    

    
    J Natl Cancer Inst

26. PISCITELLO AJ, Edwards V DK, Fransen S, Meester RGS, et al
    RE: the centers for medicare and medicaid services and others misunderstand stool testing for colorectal cancer.
    J Natl Cancer Inst. 2026 Mar 17:djag074. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

27. LABADIE KP, Vien P, Mahuron KM, Olson KA, et al
    Simultaneous Resection Is Associated With Long-Term Survival in Patients With High-Risk Synchronous Rectal Cancer Liver Metastases.
    J Surg Oncol. 2026;133:444-453.
    

    >> Share

    
    
28. AFOLARANMI O, Diehl TM, Salim Virani S, Yang Q, et al
    Survival Following Colorectal Cancer Surgery in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis.
    J Surg Oncol. 2026 Mar 15. doi: 10.1002/jso.70235.
    

    >> Share

    
    
29. BEKKI T, Shimomura M, Yano T, Imaoka K, et al
    Impact of Aspirin on Recurrence Prevention After Curative Resection for Stage I-III Colorectal Cancer: A Multi-Institutional Retrospective Study.
    J Surg Oncol. 2026 Mar 19. doi: 10.1002/jso.70217.
    

    >> Share

    
    

    
    Oncogene

30. HE H, Yuan J, Wang H, Chen L, et al
    L1TD1 promotes colorectal mucinous adenocarcinoma progression by enhancing ABCC3 mRNA stability.
    Oncogene. 2026;45:1071-1086.
    

    >> Share

    
    
31. CABALLERO-RUIZ B, Bordone R, Coni S, Gkotsi DS, et al
    Partial truncation of the C-terminal domain of PTCH1 in cancer promotes tumourigenesis by non-canonical activation of a GLI-PI3K loop.
    Oncogene. 2026;45:1013-1025.
    

    >> Share

    
    

    
    PLoS One

32. THOMPSON JH, Schneider JL, Rivelli JS, Gautom P, et al
    Implementing a successful patient navigation program for follow-up colonoscopy: Lessons from the PRECISE study.
    PLoS One. 2026;21:e0343659.
    

    >> Share

    
    
33. KHAWAJA G, Shoujaa A, El-Orfali Y, Abou Najem S, et al
    Swertiamarin fails to induce cytotoxicity in colon cancer cell lines: Evidence against a direct anticancer effect.
    PLoS One. 2026;21:e0344653.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share